Fortitude Biomedicines | RoundOS

Weekly digest by email

Loading companies…

Fortitude Biomedicines | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jan 26, 2026	Seed	$13M	Elikon Venture — Role not disclosedEverjoy Fortune — Role not disclosedK2 Bio Partners — Role not disclosedShanghai Healthcare Angel Capital (SHAC) — Role not disclosedTaihill Venture — Role not disclosed

Investors

Elikon VentureSeed Everjoy FortuneSeed K2 Bio PartnersSeed Shanghai Healthcare Angel Capital (SHAC)Seed Taihill VentureSeed

Coverage

Jan 26, 2026Fortitude Biomedicines · Seed

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

fortitudebio.com ↗